Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction. Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction.
Trending
- Steve Vai turned a California home’s gardener shack into an album studio
- Russia begins diesel exports after Trump deal amid global oil market concerns
- Born with an underdeveloped arm, he built a LEGO prosthetic at 18 to help another boy
- IISc, Samsung open quantum lab to advance research in next-gen technology
- Washington uses helicopters to fly 6,000 logs into remote streams to restore salmon habitats
- Severed head of Manipur attack victim recovered 5 days after Naga body’s discovery
- Pat Crowley’s Bel-Air home lists for nearly $16 million after more than 50 years
- Meet Holden Bierman, 19, who turned $500 loan into six-figure beachwear business
US biotech firm completes 95% of dodo genome, targets bird’s possible revival
By
Add A Comment